Product Code: NWM FDA class 2 21 CFR 862.3350

Immunoassay, Anti-Seizure Drug

Clinical Toxicology

The Immunoassay, Anti-Seizure Drug (product code NWM) is an in vitro diagnostic device used as an aid in the management of patients treated with anti-seizure medications, enabling monitoring of drug levels to guide therapeutic decisions. It is classified as FDA Class 2, requiring 510(k) clearance, and is regulated under 21 CFR 862.3350 within the Clinical Toxicology specialty. Third-party 510(k) review is available for this device type.

510(k)s
5
FEI Numbers
2
Registration Numbers
2
Unique Applicants
2
Years Active
16

Research product code NWM in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
NWM
Device Class
FDA class 2
Regulation Number
862.3350
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

To aid in management of patients treated with anti-seizure drug.

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 5 510(k) clearances via K numbers.

K Number Device Name
K201089 ARK Lacosamide Assay
K091884 ARK ZONISAMIDE ASSAY, ARK ZONISAMIDE CALIBRATOR, AND ARK ZONISAMIDE CONTRO, MODELS 5022-0001-00, 5022-0002-00, 5022-0003
K083799 TOPIRAMATE ASSAY, ARK TOPIRAMATE CALIBRATOR AND ARK TOPIRAMATE CONTROL, MODELS 5015-0001-000, 5015-0002-00, 5015-0003-00
K070645 SERADYN QMS TOPIRAMATE
K051211 QMS ZONISAMIDE REAGENTS, CALIBRATORS AND CONTROLS

FEI Numbers

This FDA classification entry is associated with 2 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 2 registration numbers. Click on an entry to view related FDA registrations.